[1]
|
Demir, S., Nawroth, P.P., Herzig, S. and Üstünel, B.E. (2021) Emerging Targets in Type 2 Diabetes and Diabetic Com-plications. Advanced Science, 8, e2100275. https://doi.org/10.1002/advs.202100275
|
[2]
|
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
|
[3]
|
Asbun, J. and Villarreal, F.J. (2006) The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy. Journal of the American College of Cardiology, 47, 693-700. https://doi.org/10.1016/j.jacc.2005.09.050
|
[4]
|
Hamby, R.I., Zoneraich, S. and Sherman, L. (1974) Diabetic Cardiomyopathy. JAMA, 229, 1749-1754.
https://doi.org/10.1001/jama.1974.03230510023016
|
[5]
|
Yang, W., Lu, J., Weng, J., et al. (2010) Prevalence of Diabetes among Men and Women in China. The New England Journal of Medicine, 362, 1090-1101. https://doi.org/10.1056/NEJMoa0908292
|
[6]
|
Ritchie, R.H. and Abel, E.D. (2020) Basic Mechanisms of Diabetic Heart Disease. Circulation Research, 126, 1501-1525.
https://doi.org/10.1161/CIRCRESAHA.120.315913
|
[7]
|
Jia, G., Whaley-Connell, A. and Sowers, J.R. (2018) Diabetic Cardiomyopathy: A Hyperglycaemia- and Insulin- Resistance-Induced Heart Disease. Diabetologia, 61, 21-28. https://doi.org/10.1007/s00125-017-4390-4
|
[8]
|
邹燕珂, 黄晶, 熊波, 等. 三维斑点追踪成像评价糖尿病患者心脏损害的Meta分析[J]. 中国介入影像与治疗学, 2017, 14(2): 86-91.
|
[9]
|
梁丽媚, 刘红利, 张会欣, 等. 三维斑点追踪成像评价代谢因素对2型糖尿病患者左室结构和功能的影响[J]. 临床心血管病杂志, 2021, 37(12): 1111-1116.
|
[10]
|
Chen, X., Guo, H., Yang, Q., et al. (2020) Quantitative Evaluation of Subclinical Left Ventricular Dysfunction in Patients with Type 2 Diabetes Mellitus by Three-Dimensional Echocardiography. The International Journal of Cardiovascular Imaging, 36, 1311-1319. https://doi.org/10.1007/s10554-020-01833-5
|
[11]
|
彭松夏, 徐怡, 孙霞, 等. 三维斑点追踪技术评价糖尿病足患者左室功能的价值[J]. 临床超声医学杂志, 2020, 22(10): 789-792.
|
[12]
|
成珍珍, 刘勇. 三维斑点追踪成像定量评价2型糖尿病患者左室收缩功能[J]. 临床超声医学杂志, 2020, 22(6): 411-414.
|
[13]
|
陈峥, 桂书彦, 李加平, 等. 三维超声联合斑点追踪对2型糖尿病患者心脏功能早期损伤应用分析[J]. 医学影像学杂志, 2022, 32(5): 865-868.
|
[14]
|
黎涛. 糖化血红蛋白、同型半胱氨酸、纤维蛋白原与2型糖尿病患者微血管病变的相关性[J]. 海南医学, 2012, 23(24): 91-93.
|
[15]
|
国蓉, 李肖珏, 陈燕燕. 糖化血红蛋白在糖尿病筛查和诊断中的意义[J]. 海军军医大学学报, 2023, 44(4): 480-485.
|
[16]
|
Lee, J. and Cho, J.H. (2021) Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diag-nosed Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal, 45, 337-338.
https://doi.org/10.4093/dmj.2021.0078
|
[17]
|
Zhao, H., Zhang, L.D., Liu, L.F., et al. (2021) Blood Levels of Gly-cated Hemoglobin, D-Dimer, and Fibrinogen in Diabetic Retinopathy. Diabetes, Metabolic Syndrome and Obesity, 14, 2483-2488.
https://doi.org/10.2147/DMSO.S309068
|
[18]
|
刘芳, 石晶, 张军, 等. 应用三维斑点追踪技术评价2型糖尿病患者左心室收缩功能[J]. 中国医学影像技术, 2013, 29(5): 752-756.
|
[19]
|
汤春梦, 李文和, 杨超超, 等. 血红蛋白糖化指数与2型糖尿病患者视网膜病变的相关性研究[J]. 中国糖尿病杂志, 2021, 29(5): 349-352.
|
[20]
|
唐明照, 吴吕燕. Cys-C、HCY、Hs-CRP、β2-MG、Cr联合检测对糖尿病肾病诊断的应用价值[J]. 海南医学, 2012, 23(3): 86-87.
|
[21]
|
Kim, K.J., Choi, J., Bae, J.H., et al. (2021) Time to Reach Target Glycosylated Hemoglobin Is Associated with Long- Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study. Diabetes & Metabolism Journal, 45. 368-378.
https://doi.org/10.4093/dmj.2020.0046
|
[22]
|
谢娟娟, 刘明辉, 赵白桦, 等. 实时三平面组织多普勒成像技术评价糖尿病患者左心室功能及与HbA1c的关系[J]. 中国医学影像技术, 2010, 26(9): 1695-1699.
|
[23]
|
邱顺平, 李志荣, 王亚, 等. 三维斑点追踪技术评估2型糖尿病早期左室心肌应变及与糖化血红蛋白的相关性研究[J]. 中国当代医药, 2019, 26(28): 173-175, 179.
|
[24]
|
吴凌恒, 陈建雄, 张梦娇, 等. 血糖控制不理想对2型糖尿病患者亚临床心肌收缩功能的影响研究[J]. 上海交通大学学报(医学版), 2023, 43(8): 1024-1031.
|
[25]
|
Selvin, E., Lazo, M., Chen, Y., et al. (2014) Diabetes Mellitus, Prediabetes, and Incidence of Subclinical Myocardial Damage. Circulation, 130, 1374-1382. https://doi.org/10.1161/CIRCULATIONAHA.114.010815
|
[26]
|
Ortiz-Martínez, M., Gonzá-lez-González, M., Martagón, A.J., et al. (2022) Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus. Current Diabetes Reports, 22, 95-115.
https://doi.org/10.1007/s11892-022-01453-4
|
[27]
|
El Hayek, M.S., Ernande, L., Benitah, J.P., et al. (2021) The Role of Hyperglycaemia in the Development of Diabetic Cardiomyopathy. Archives of Cardiovascular Diseases, 114, 748-760. https://doi.org/10.1016/j.acvd.2021.08.004
|
[28]
|
Guido, M.C., Marques, A.F., Tavares, E.R., et al. (2017) The Effects of Diabetes Induction on the Rat Heart: Differences in Oxidative Stress, Inflammatory Cells, and Fibrosis between Subendocardial and Interstitial Myocardial Areas. Oxidative Medicine and Cellular Longevity, 2017, Article ID: 5343972. https://doi.org/10.1155/2017/5343972
|
[29]
|
应康, 郭良云, 刘燕娜, 等. 基于三维斑点追踪成像评估左心室心肌应变对2型糖尿病患者发生主要不良心脏事件的预测[J]. 中国超声医学杂志, 2023, 39(8): 883-886.
|
[30]
|
Avagimyan, A., Popov, S. and Shalnova, S. (2022) The Pathophysiological Basis of Diabetic Cardiomy-opathy Development. Current Problems in Cardiology, 47, Article ID: 101156. https://doi.org/10.1016/j.cpcardiol.2022.101156
|
[31]
|
Frustaci, A., Kajstura, J., Chimenti, C., et al. (2000) Myocar-dial Cell Death in Human Diabetes. Circulation Research, 87, 1123-1132. https://doi.org/10.1161/01.RES.87.12.1123
|
[32]
|
Seferović, P.M. and Polovina, M. (2020) In Search of a “Safety Zone” for Glycaemic Control: Association between Glycosylated Haemoglobin Levels and Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease. European Journal of Heart Failure, 22, 2035-2037. https://doi.org/10.1002/ejhf.1981
|